News

17/06/2008
LONDON GENETICS LAUNCHES MOLECULAR CYTOGENETICS SERVICE AT INTERNATIONAL BIOTECHNOLOGY CONFERENCE BIO2008

22/05/2008
LONDON GENETICS WILL BE PRESENTING AT THE EPIC BIOTECH CONFERENCE ON THE 22nd May 2008

Events

17/11/2008
BIO-EUROPE
The largest European stand-alone partnering conference for the global biotechnology industry Mannheim/Heidelberg Germany

11/11/2008
THE AMERICAN SOCIETY OF HUMAN GENETICS
58th Annual Meeting Philadelphia, Pennsylvania, USA

Partner Licensing Opportunities

A range of novel technologies have been developed within our partner institutions, and several of these are available for licensing. If you would like further information on any of the following technologies, please contact us.

Current licensing opportunities on offer include:

High Density Oligonucleotide Array Fabrication Technology
Genetic variation that can predict response to bisphosphonates
Mutation associated with the spread of cancer
SCN1A: a genetic predictor for the use of drugs for epilepsy and other neurological conditions
KCNV2: a novel mutation linked to Inhibition Response Failure
RIMS1: a novel target for enhancement of cognitive function
Indicators of therapeutic efficacy of Remicade (Infliximab)
A new model of Attention Deficit Hyperactivity Disorder (ADHD): screening for new drug treatments and genetic markers for ADHD